High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women

被引:57
作者
Ravn, P
Rix, M
Andreassen, H
Clemmesen, B
Bidstrup, M
Gunnes, M
机构
[1] ROSKILDE CTY HOSP KOGE,DEPT INTERNAL MED,ROSKILDE,DENMARK
[2] CTR CLIN OSTEOPOROSIS RES,HAUGESUND,NORWAY
关键词
tiludronate; postmenopausal osteoporosis; urinary CrossLaps; osteocalcin; bone mineral density; spinal fracture; osteoporosis;
D O I
10.1007/s002239900225
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis, Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm(2), and 278 women had a BMD below 0.860 g/cm2. Spinal fracture was diagnosed from lateral spine X-ray studies and defined as at least 20% height reduction (wedge, compression, or endplate fracture) in at least one vertebra (T4-L4), Bone resorption was assessed by measurement of the urinary excretion of type I collagen degradation products by the CrossLapsTM enzyme-linked immunoassay (ELISA). Bone formation was assessed by ELISA measurement of the N-terminal-midfragment as well as the intact serum osteocalcin (OCN-MID), thus omitting the influence of the instability of osteocalcin caused by the labile 6 amino acid C-terminal sequence. The women were divided into groups with high or low bone turnover according to the concentrations of urinary CrossLapsTM or OCN-MID. Women in the quartiles with the highest concentrations of CrossLaps [519 +/- 119 mu g/mmol (SD)] or OCN-MID [44.6 +/- 7.5 ng/ml (SD)] had 10-16% lower spinal BMD compared with women in the lowest quartiles (CrossLaps 170 +/- 48 mu g/mmol (SD), and OCN-MID [22.1 +/- 3.0 ng/ml (SD)] (P < 0.0004). The prevalences of spinal fracture were 25 to 29% in the lowest quartiles, whereas the prevalences in the highest quartiles were almost double-53-54% (P < 0.006). If the women were subgrouped according to spinal BMD and prevalence of spinal fracture, corresponding results were found. Women with a BMD less than 0.860 g/cm(2), without or with spinal fracture (n = 136 and n = 142), had 36-43% higher concentration of CrossLaps (P = 0.0001) and 11-15% higher concentration of OCN-MID (P < 0.02), as compared with women with a BMD above 0.860 g/cm(2) and no spinal fracture (n = 84). In conclusion, the results indicate a strong association among high bone turnover, low bone mass, and prevalence of spinal fracture, which supports the theory that high bone turnover is a risk factor for spinal fracture and osteoporosis.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 22 条
[1]
BJAMASON K, 1995, OSTEOPROSIS INT, V5, P35
[2]
APPLICATIONS OF AN ENZYME-IMMUNOASSAY FOR A NEW MARKER OF BONE-RESORPTION (CROSSLAPS) - FOLLOW-UP ON HORMONE REPLACEMENT THERAPY AND OSTEOPOROSIS RISK ASSESSMENT [J].
BONDE, M ;
QVIST, P ;
FLEDELIUS, C ;
RIIS, BJ ;
CHRISTIANSEN, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :864-868
[3]
BONDE M, 1994, CLIN CHEM, V40, P2022
[4]
CHRISTIANSEN C, 1984, ACTA MED SCAND, V216, P11
[5]
COMPARISON OF NEW BIOCHEMICAL MARKERS OF BONE TURNOVER IN LATE POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN RESPONSE TO ALENDRONATE TREATMENT [J].
GARNERO, P ;
SHIH, WCJ ;
GINEYTS, E ;
KARPF, DB ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1693-1700
[6]
GARNERO P, 1995, J BONE MINER RES, V10, P641
[7]
ASSESSMENT OF BONE-RESORPTION WITH A NEW MARKER OF COLLAGEN DEGRADATION IN PATIENTS WITH METABOLIC BONE-DISEASE [J].
GARNERO, P ;
GINEYTS, E ;
RIOU, JP ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) :780-785
[8]
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis [J].
Garnero, P ;
SornayRendu, E ;
Chapuy, MC ;
Delmas, PD .
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (03) :337-349
[9]
GERTZ BJ, 1994, J BONE MINER RES, V9, P135
[10]
HANSEN MA, 1990, J NUCL MED, V31, P1156